Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated reanalysis of genomic data for rare disease diagnostics at scale.

Nature medicine·2026
Same author

Cardiomyopathy and Sudden Cardiac Death as a Rare Presentation of Mucolipidosis Type III in a Family With Compound Heterozygous Variants in <i>GNPTAB</i>.

Circulation. Genomic and precision medicine·2026
Same author

The Evidence Aggregator: AI reasoning applied to rare disease diagnostics.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026
Same author

Saturation editing of RNU4-2 reveals distinct dominant and recessive disorders.

Nature·2026
Same author

Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026
Same journal

Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV.

Genome medicine·2026
Same journal

Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer.

Genome medicine·2026
Same journal

Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK.

Genome medicine·2026
Same journal

Identification and functional characterization of regulatory variants in DPP9 associated with COVID-19 severity.

Genome medicine·2026
Same journal

De novo variants in NPTN cause a neurodevelopmental disorder with autism and neuroplastin-PMCA hypofunction.

Genome medicine·2026
Same journal

Dual functional genomics reveals a broad and convergent landscape of asciminib resistance in BCR::ABL1.

Genome medicine·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Challenges in clinical genomics.

Daniel G Macarthur1

  • 1Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA. macarthur@atgu.mgh.harvard.edu.

Genome Medicine
|May 25, 2012
PubMed
Summary
This summary is machine-generated.

Genomic disorders and rare diseases were discussed at a 2012 meeting. Advances in genomics are improving the understanding and diagnosis of these conditions.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Experiment Videos

Last Updated: May 22, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Genomics
  • Rare Diseases
  • Medical Genetics

Background:

  • The Genomics of Rare Diseases meeting convened in 2012.
  • It brought together experts to discuss genomic disorders.
  • Rare diseases collectively affect a significant portion of the population.

Purpose of the Study:

  • To report on the key discussions and findings from the Genomic Disorders 2012 meeting.
  • To highlight advancements in the genomics of rare diseases.
  • To foster collaboration and knowledge sharing in the field.

Main Methods:

  • The report summarizes presentations and discussions from the meeting.
  • Key themes included genomic technologies and their application to rare diseases.
  • Expert insights into genetic variations and disease mechanisms were shared.

Main Results:

  • Genomic approaches are revolutionizing the diagnosis of rare diseases.
  • Understanding the genetic basis of rare conditions is advancing rapidly.
  • New technologies facilitate comprehensive genomic analysis.

Conclusions:

  • Continued research and application of genomics are crucial for rare disease understanding.
  • Improved diagnostic strategies are emerging from genomic studies.
  • The meeting underscored the importance of international collaboration in genomic research.